Fortress Biotech (FBIO) EPS (Diluted) Growth (3y) (2021 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) EPS (Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 7.01% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 12.90% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 82.91% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 36.83% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 36.39% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -36.81% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 67.51% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 72.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.26% |
| Dec 31, 2025 | 64.29% |
| Sep 30, 2025 | 26.56% |
| Jun 30, 2025 | 28.33% |
| Mar 31, 2025 | 61.77% |
| Dec 31, 2024 | 66.66% |
| Sep 30, 2024 | 57.58% |
| Jun 30, 2024 | 55.78% |
| Mar 31, 2024 | 44.01% |
| Dec 31, 2023 | 39.19% |
| Sep 30, 2023 | 48.84% |
| Jun 30, 2023 | 18.10% |
| Mar 31, 2023 | 15.16% |
| Dec 31, 2022 | 14.28% |
| Sep 30, 2022 | 11.18% |
| Jun 30, 2022 | 15.13% |
| Mar 31, 2022 | -31.07% |
| Dec 31, 2021 | 5.23% |
| Sep 30, 2021 | 0.28% |
| Jun 30, 2021 | 13.70% |